Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;30(1):25-26.
doi: 10.1016/j.tracli.2022.08.002. Epub 2022 Aug 5.

Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021

Pierre Gallian  1 , Ahmed Slimani  2 , Lucile Malard  3 , Pascal Morel  3 , Xavier de Lamballerie  4
Affiliations

Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021

Pierre Gallian et al. Transfus Clin Biol. 2023 Feb.
No abstract available

Keywords: SARS-CoV-2; Seroprevalence; Vaccine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Distribution of quantitative results in seropositive individuals when tested using the Access SARS-CoV-2 IgG II, Beckman assay according to the vaccine status. Legend: red diamond = mean; Box = 1st quartile - median – 3rd quartile; Whiskers = 1st decile – 9th decile.
See this image and copyright information in PMC

References

    1. Gallian P., Pastorino B., Morel P., Chiaroni J., Ninove L., de Lamballerie X. Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors. Antiviral Res. 2020;181 - PMC - PubMed
    1. Stone M., Di Germanio C., Wright D.J., Sulaeman H., Dave H., et al. Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program. Clin Infect Dis. 2021 doi: 10.1093/cid/ciab537. - DOI - PMC - PubMed
    1. Slot E.d., Hogema B.M., Reusken C.B.E.M., Reimerink J.H., Molier M., Karregat J.H.M., et al. Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands. Nat Commun. 2020;11(1) doi: 10.1038/s41467-020-19481-7. - DOI - PMC - PubMed
    1. Whitaker H.J., Elgohari S., Rowe C., Otter A.D., Brooks T., et al. Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021. J Infect. 2021;83:237–279. - PMC - PubMed
    1. Jones J.M., Stone M., Sulaeman H., Fink R.V., Dave H., Levy M.E., et al. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021. JAMA. 2021;326(14):1400. doi: 10.1001/jama.2021.15161. - DOI - PMC - PubMed

Substances